JointHealth™ express April 8, 2015
Annual JointHealth™ Medications Guide: A consumer's guide to arthritis medications
The reliable, quick reference arthritis medications guide you need to assist you and your health care team with your therapy conversations
This year’s JointHealth™ Medications Guide gives you, our member, subscriber and on-line visitor concise, fact-based information on the most commonly prescribed medications for inflammatory types of arthritis and osteoarthritis. Feature articles about new medications and scientific advances that give a deeper understanding of the importance of timely initiation of medication therapy in appropriate doses, and a patient’s perspective on the therapy conversation, are key pieces that lead toward “personalized medicine”.
Medication information for the following diseases is included in this year’s guide: rheumatoid arthritis, spondyloarthritis, (systemic) juvenile idiopathic arthritis, psoriatic arthritis, systemic lupus erythematosus, vasculitis, osteoarthritis, and osteoporosis.
In this JointHealth™ monthly, you will also find:
Annual JointHealth™ Medications Guide: A consumer's guide to arthritis medications
The reliable, quick reference arthritis medications guide you need to assist you and your health care team with your therapy conversations
This year’s JointHealth™ Medications Guide gives you, our member, subscriber and on-line visitor concise, fact-based information on the most commonly prescribed medications for inflammatory types of arthritis and osteoarthritis. Feature articles about new medications and scientific advances that give a deeper understanding of the importance of timely initiation of medication therapy in appropriate doses, and a patient’s perspective on the therapy conversation, are key pieces that lead toward “personalized medicine”.
Medication information for the following diseases is included in this year’s guide: rheumatoid arthritis, spondyloarthritis, (systemic) juvenile idiopathic arthritis, psoriatic arthritis, systemic lupus erythematosus, vasculitis, osteoarthritis, and osteoporosis.
In this JointHealth™ monthly, you will also find:
- An explanation of a new targeted small molecule medication and a subsequent entry biologic approved in Canada in 2014.
- An interview with Alison Hoens, a woman living with rheumatoid arthritis, about therapy choices.
- A history of methotrexate as an arthritis treatment.
- Emerging research in the field of personalized medicine.
Arthritis Consumer Experts
ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealth™ information and education programs.